#neuroonc posters

Interested in attending the SNO annual meeting?? SNO has 2 scholarships for the meeting, one for URIM early healthcare professionals and one for international attendees! soc-neuro-onc.org/WEB/About_Cont… SNO

Great job Katy Peters presenting data from the INDIGO trial at #AANAM!!!

Big congratulations to Dr. Yazmin Odia on receiving Neuro-Oncology Investigator Award Oncology at #AANAM !!! Katy Peters delivering the award 🥇 to esteemed recipient !

Great work by Joshua Budhu Memorial Sloan Kettering Cancer Center MSKCC Immigrant Health & Cancer Disparities Center: practical tools to provide equitable cancer care to underserved patients. Patient navigators are key to ensuring pts can access resources & clin trials during rx for cancer #HealthEquity Weill Cornell Neurology

It was nice to catch up with so many of my favorite neurologists last night 🧠 Here’s Day 5 #NeuroOnc highlights for today! #AANAM American Academy of Neurology Katy Peters Nimish Mohile (he/him) Andrea Wasilewski MD Jacob Mandel PhiOanh "Leia" NghiemPhu, MD Maciej M Mrugala, MD, PhD, MPH, FAAN Yasmin Khakoo, MD, FAAN, FCNS, FAAP (she/hers) Joshua Budhu Lauren Schaff, MD

Thanks Christy Soares (so-ARE-ez), MD - this picture embodies the neuro-onc section and all the fun we had at #AANAM!

📣 We have one more #NeuroOnc content to highlight on this last day of American Academy of Neurology #AANAM 2024! Tune in in-person / on-line 💻 Katy Peters Nimish Mohile (he/him) PhiOanh "Leia" NghiemPhu, MD Jacob Mandel Andrea Wasilewski MD Lauren Schaff, MD Yasmin Khakoo, MD, FAAN, FCNS, FAAP (she/hers) Jennie Taylor Joshua Budhu DeniseLeungMD

Monday at #ASCO2024: Niraparib + XRT Phase 0/2 in Newly Diagnosed, MGMT-Unmethylated GBM OS= 20.3 months #Gliofocus Study coming in June: a global, label-enabling, Ivy Brain Tumor Center-sponsored, head-to-head Phase 3 trial in partnership with GSK

#ASCO24 analysis from Roger Stupp practiceupdate.com/expertopinion/…

Join us tomorrow ASCO #ASCO24 #btsm All what you need to know about IDHm gliomas with Drs. Wen, Preusser and Dr Florien Boele Sylvester Comprehensive Cancer Center SNO

Insightful poster by Dr. Yoshie Umemura on BDTX-1535, assessing its PK, PD, & clinical responses in recurrent HGG & EGFR alterations. BDTX-1535 was well-tolerated, reaches effective concentrations in non-enhancing tumor tissue & is linked to the suppression of EGFR signaling.👏

Advancing clinical trials: ST101 targeting C/EBPBeta, switching M2 to M1 macrophages achieves tumor penetration and increases lymphocyte and macrophage infiltration #ASCO24

Are you or a loved one battling a recurrent high-grade glioma? Consider enrolling in an Ivy Center clinical trial to access novel investigational treatments. Connect with us today. 🧠🔬 🌐 loom.ly/_YcKLPA ☎️ 602-406-8605 ✉️ [email protected]

Come behind the scenes w/me at #ASCO24 as a person living w/a malignant brain tumor… who is also faculty: 📸accessible shower 📸anti-seizure meds 📸practicing talking about numbers due to neuro deficits from surgery (acalculia) 📸invisible illness #NationalCancerSurvivorsDay

Promising interim survival & best in class brain penetration noted in this phase 0/2 Niraparib trial Ivy Brain Tumor Center in new GBM ⭐️ Nader Sanai will be talking more about the upcoming phase 3 trial tonight at the meet the expert session!

Wow, remarkable and perhaps practice changing data from this observational study comparing traditional treatment (RT -> PCV) for anaplastic oligodendroglioma with RT + TMZ. Will be interesting to see the results of CODEL. #ASCO24

Looking forward to enrolling patients on the Gliofocus trial Nader Sanai Yoshie Umemura

We are proud to sponsor the annual American Brain Tumor Association National Conference. This event looks at the latest breakthroughs in brain tumor research, treatment, & care. Don't miss this opportunity! Registration is now open! 📆 September 5-7, 2024 🌐 Virtual & Chicago 🔗 loom.ly/08unjhU

I love our #neuroonc team and shared sense of humor ❤️🧠